Tiziana Life Sciences PLC Shares 2011-2026 | TLSA

Annual Shares Tiziana Life Sciences PLC

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	97.9 M	68.2 M	68.2 M	63.8 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
97.9 M	63.8 M	74.5 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Altimmune ALT	88.1 M	$ 3.47	3.89 %	$ 306 M	USA
I-Mab IMAB	187 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	54.8 M	$ 219.83	-0.92 %	$ 5 B	Danmark
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	16.8 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.08 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	1.24 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	19.2 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	17.9 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	12.1 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Grifols, S.A. GRFS	682 M	$ 7.69	1.39 %	$ 6.83 B	Spain
Avenue Therapeutics ATXI	1.3 M	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	19.8 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	15.8 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
CollPlant Biotechnologies Ltd. CLGN	11.5 M	$ 0.6	-2.83 %	$ 6.87 M	Israel
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	60.2 M	$ 13.01	2.12 %	$ 784 M	USA
Atreca BCEL	38.6 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	99.3 M	-	-4.8 %	$ 255 M	USA
Heron Therapeutics HRTX	167 M	$ 0.8	2.29 %	$ 133 M	USA
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	73.9 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	54.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	69.9 K	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	9.55 M	-	-74.18 %	$ 955 K	USA
Incyte Corporation INCY	195 M	$ 91.13	0.38 %	$ 17.8 B	USA
Checkpoint Therapeutics CKPT	39.7 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	116 M	-	-7.23 %	$ 13 M	USA
Inovio Pharmaceuticals INO	22.2 M	$ 1.6	0.95 %	$ 35.5 M	USA
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
Denali Therapeutics DNLI	164 M	$ 21.15	4.86 %	$ 3.48 B	USA
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
Inventiva S.A. IVA	39.2 M	$ 6.07	5.02 %	$ 138 M	France
Arbutus Biopharma Corporation ABUS	166 M	$ 4.3	1.3 %	$ 714 M	Canada
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	6.18 M	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCC	22.3 M	-	-5.98 %	$ 34.1 M	USA
Decibel Therapeutics DBTX	25 M	-	-	$ 123 M	USA
Deciphera Pharmaceuticals DCPH	85.1 M	-	-	$ 2.18 B	USA
Cardiff Oncology CRDF	66.8 M	$ 1.8	0.08 %	$ 120 M	USA